Treatment, enhancement, and the ethics of neurotherapeutics

Brain and Cognition

Volumn 50, Issue 3, 2002, Pages 387-395

  Wolpe, Paul Root ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; BRAIN DEPTH STIMULATION; HISTORY; IMAGING; MEDICAL ETHICS; MENTAL FUNCTION; PHILOSOPHY; PRIORITY JOURNAL; SKILL; SOCIAL ASPECT; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT INDICATION;

HEALTH CARE AND PUBLIC HEALTH;

BIOETHICS; BRAIN DISEASES; COGNITION; DRUG THERAPY; HUMANS; PSYCHOTROPIC DRUGS;

EID: 0036936519     PISSN: 02782626     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-2626(02)00534-1     Document Type: Article

References (29)

1. Abbott, A. (2001). Into the mind of a killer. Nature, 410, 296-298.
2. Anderson, S. W., Bechara, A., Damasio, H., Tranel, D., & Damasio, A. R. (1999). Impairment of social and moral behavior related to early damage in human prefrental cortex. Nature Neuroscience, 2(11), 1032-1037.
3. Armstrong, K., Schwartz, J. S., & Asch, D. A. (1999). Direct sale of sildenafil (Viagra) to consumers over the internet. New England Journal of Medicine, 341(18), 1389-1392.
4. Bastuji, H., & Jouvet, M. (1988). Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil. Progress in Neuro psychopharmacology & Biological Psychiatry, 12(5), 695-700.
5. Caldwell, J. A., Caldwell, J. L., Smythe, N. K., & Hall, K. K. (2000). A double-blind, placebo-controlled investigation of the efficacy of modafinil for sustaining the alertness and performance of aviators: A helicopter simulator study. Psychopharmacologia, 150(3), 272-282.
6. CBS News, A Dream Come True? New Drug Tricks Brain to be Awake; Military Is Interested. January 14, 2002. (http://www.cbsnews.com/now/story/0,1597,324299-412,00.shtml).
7. Daniels, N. (2000). Normal functioning and the treatment-enhancement distinction. Cambridge Quarterly, 9(3), 309-322.
8. Daniels, N. (1985). Just Health Care. New York: Cambridge University Press.
9. Diller, L. H. (1996). The run on Ritalin: Attention deficit disorder and stimpulant treatment in the 1990s. Hastings Center Report, 26(2), 12-14.
10. Furey, M. L., Pietrini, P., Alexander, G. E., Schapiro, M. B., & Horwitz, B. (2000). Cholinergic enhancement improves performance on working memory by modulating the functional activity in distinct brain regions: A positron emission tomography regional cerebral blood flow study in healthy humans. Brain Research Bulletin, 51(3), 213-218.
11. Goode, E. (1998). New hope for losers in the battle to stay awake. New York Times, November 3, F1.
12. Groopman, J. (2001). Eyes wide open. The New Yorker, December 3, 52-57.
13. Juengst, E. (1998). What does enhancement mean?. In E. Parens (Ed.), Enhancing Human Traits (pp. 29-47). Washington, DC: Georgetown University Press.
14. Kramer, P. O. (1993). Listening to Prozac. New York: Penguin books.
15. Lachs, J. (2000). Grand dreams of perfect people. Cambridge Quarterly, 9(3), 323-329.
16. Los Angeles Times (2002). EDA Reprimands 4 Drug Makers for Misleading Promotions. January 16. (http: //www.latimes.com/business/la-000004018janl 6.story?col=la-headlines-business).
17. Legarde, D., Batejat, D., van Beers, P., Sarafian, D., & Pradella, S. (1995). Interest of modafinil, a new psychostimulant during a sixty hour sleep deprivation experiment. Fundamental & Clinical Pharmacology, 9(3), 271-279.
18. Lyons, T. J., & French, J. (1991). Modafinil the unique properties of a new stimulant. USAF School of Aerospace, Brooks TX Science News Note, 62, 432-435.
19. Miller, A. R., Lalonde, C. E., McGrail, K. M., & Armstrong, R. W. (2001a). Prescription of methylphenidate to children and youth, 1990-1996. CMAJ, Canadian Medical Association Journal, 165(11), 1489-1494.
20. Miller, M. D., Seeley, W. W., Mychack, P., Rosen, M. D., Mena, I., & Boone, K. (2001b). Neuroanatomy of the self. Neurology, 57, 817-821.
21. Parens, E. (1998). Is better always good? The enhancement project. Hastings Center Report, 28(1), S1-S15.
22. Sabin, J. E., & Daniels, N. (1994). Determining 'medical necessity' in mental health practice. Hastings Center Report, 24(6), 5-13.
23. Silvers, A. (1998). A fatal attraction to normalizing, treating disabilities as deviations from "species-typical" functioning. In E. Parens (Ed.), Enhancing Human Traits (pp. 95-123). Washington, DC: Georgetown University Press.
24. Slater, L. (1998). Prozac Diary. New York: Random House.
25. Tang, Y. P., Shimizu, E., Dube, G. R., Rampon, C., Kerchner, G. A., Zhuo, M., Liu, G., & Tsien, J. Z. (1999). Genetic enhancement of learning and memory in mice. Nature, 401(6748), 63-69.
26. Tang, Y., Shimizu, E., & Tsien, J. Z. (2001). Do 'smart' mice feel more pain, or are they just better learners? Nature Neuroscience, 4(5), 453-454.
27. US Modafinil in Narcolepsy Multicenter Study Group (2000). Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy. Neurology 54(5), 1166-1175.
28. Wei, F., Wang, G. D., Kerchner, G. A., Kim, S. J., Xu, H. M., Chen, Z. F., & Zhuo, M. (2001). Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nature Neuroscience, 4(2), 164-169.
29. Whitehouse, P. J., Juengst, E., Mehlman, M., & Murray, T. H. (1997). Enhancing cognition in the intellectually intact. Hastings Center Report, May-June, 14-22.